☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
gilead sciences
Gilead Sciences to Acquire CymaBay Therapeutics for ~$4.3B
February 13, 2024
Top Performing Drug of 2021 – Biktarvy (October Edition)
October 27, 2022
Top 20 BioPharma Companies based on 2020 Total Revenue
April 8, 2021
Top 20 Biopharma M&A of 2020 by Total Deal Value
January 7, 2021
Top 20 Prescription Drugs Based on 2019 Revenue
July 17, 2020
PharmaShots Weekly Snapshot (August 12-16, 2019)
August 19, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.
